Anesthesia, Local, Pain, Postoperative, Prostate Cancer
Conditions
Keywords
Pain, Postoperative, Ultrasound Guided Erector Spinae Plane Block, Prostatectomy
Brief summary
In the proposed study, a bilateral erector spinae plane (ESP) block \[10 ml 1%lidocaine + 10 ml 0.5 % bupivacaine vs normal saline (NS)\] will be performed preoperatively to patients undergoing open radical prostatectomy. Analgesic efficacy will be assessed on the numeric rating scale (NRS) along with intra- and 24 h post-operative narcotic consumption.
Detailed description
It has been reported that the ESP block produces effective postoperative analgesia for abdominal surgeries by relieving both somatic and visceral pain. In the present study, the investigators presume that an ESP block will decrease narcotic consumption and NRS values both intraoperatively and during the first 24 postoperative hours. Patients will be divided into two groups: Group LB (Lidocaine-Bupivacaine): A bilateral ESP block will be performed preoperatively (10 ml 1%lidocaine + 10 ml 0.5% bupivacaine). In addition, IV morphine patient-controlled analgesia (PCA) will be applied postoperatively for 24 hours. Group S: A bilateral ESP block will be performed preoperatively (20 ml NS).In addition, IV morphine-PCA will be applied postoperatively for 24 hours.
Interventions
PROCEDURESingle-injection ultrasound-guided bilateral erector spinae plane (ESP) block-Sham
With the patient in the sitting position, 20 ml normal saline will be administered between the T11 spinous process and the erector spinae muscles with the guidance of an ultrasound probe placed on a parasagittal plane. Intraoperative analgesia: after anesthesia induction, paracetamol 1 gr intravenous (IV)+ tenoxicam 20 mg IV + morphine 0.05 mg/kg IV (max 4 mg). Postoperative analgesia: IV morphine patient-controlled analgesia (PCA) of 0.5 mg/ml morphine (demand dose 1 mg; lockout interval 8 m; 6 mg/h limit).
PROCEDURESingle-injection ultrasound-guided bilateral erector spinae plane block-Lidocaine/Bupivacaine
With the patient in the sitting position, 10 ml 1% lidocaine + 10 ml 0.5% bupivacaine will be administered between the T11 spinous process and the erector spinae muscles with the guidance of an ultrasound probe placed on a parasagittal plane. Intraoperative analgesia: After anesthesia induction, paracetamol 1 gr IV + tenoxicam 20 mg IV + morphine 0.05 mg/kg IV (max 4 mg). Postoperative analgesia: IV PCA of 0.5 mg/ml morphine (demand dose 1 mg; lockout interval 8 m; 6 mg/h limit).
OTHERPain follow-up and monitorization
Numeric Rating Scale (NRS) pain score will be recorded from 15th minute in recovery room followed by 1.-3.-6.-12.-18.-24.hours with two different conditions which are at rest and while couching.If NRS score becomes ≥4 Dexketoprofen 50 mg will be administered (max 4 times).
Sponsors
Ondokuz Mayıs University
BURHAN DOST
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
DOUBLE (Subject, Caregiver)
Eligibility
Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No
Inclusion criteria
AmericanSociety of Anesthesiologists (ASA) I-III patients between the ages of 18 and 65 who are scheduled for elective open radical prostatectomy.
Exclusion criteria
* Patients who do not give informed consent or do not want to participate in the study * Ages \<18 or\>65 * ASA IV patients * Obesity (\>100 kg, BMI \>35 kg/m2) * Contraindications of regional anesthesia (coagulopathy, thrombocytopenia, or infection at injection site) * Serious renal, cardiac, or hepatic disease * Hypersensitivity to local anesthetics or a history of allergy * History of opioid or steroid use longer than four weeks * Psychiatric disorders * Analgesic preoperative treatment within the preceding 48 hours * In order to establish better standard surgery, operations shorter than 60 minutes and longer than 180 minutes will also be excluded
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Narcotic consumption in the first 24 hours after surgery | Postoperative day 1 | Morphine consumption in the first 24 hours will be measured by IV PCA. Patients will be able to request opioids via a PCA device when their NRS score is above 3. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Postoperative pain: NRS score | Postoperative day 1 | Pain status at rest and while coughing will be assessed by NRS score at 1, 3, 6, 12, 18, and 24 hours after surgery. In addition, the time until first analgesic requirement will be recorded.The NRS is an 11-point numeric scale which ranges from 0 to 10. |
| Postoperative nausea and vomiting (PONV) | Postoperative day 1 | The patients will be verbally evaluated according to a descriptive five-point PONV scale. If a score of 3 or more is registered, ondansetron 4 mg IV will be administered and repeated after 8 hours if required.The PONV scale is 0 = no nausea; 1 = slight nausea; 2 = moderate nausea; 3 = vomiting once;and 4 = vomiting more than once |
| Intraoperative remifentanil consumption | Postoperative day 1 | Following anesthesia induction, a bispectral index (BIS) of 40 to 50 will be maintained with sevoflurane. When the BIS measures 40-50, the remifentanil infusion rate will be adjusted to consider ±20% blood pressure changes compared to baseline values.The total amount of remifentanil consumed will be recorded. |
Countries
Turkey (Türkiye)
Outcome results
None listed